Mercy Medical Center North Iowa
Mercy - North Iowa to Add Cardiac/Vascular Hybrid Procedure Room
Start Date

Mercy Medical Center - North Iowa will add a Cardiac/Vascular Hybrid procedure room to its  Catheterization Labs.  The new procedure lab will be a “hybrid” lab for both cardiac  and vascular catheterizations and will improve patient flow and timeliness of the procedures.  This will be the first hybrid catheterization lab in the state of Iowa and is a critical element of the establishment of a Vascular Institute at the medical center.

 At a hearing on Wednesday, May 23, the Iowa Department of Public Health granted a Certificate of Need to Mercy – North Iowa, allowing the project to move forward.  The project includes 11,040 square feet of renovated space on the 2nd floor of Mercy – North Iowa’s East Campus.  To accommodate the expansion, nearly 5,500 square feet of office space will be relocated. 

 The existing two-cath lab suite will be relocated and expanded to allow for more room in each lab.  The relocation will also provide a better flow and relationship to the third cath lab.  The design phase is scheduled to begin in August of 2012.  Mercy officials expect construction to be completed by December of 2013. 

Mitch Morrison, Director of the Heart Center, says the third catheterization lab will be a great addition to North Iowa. 

“This new cath lab will allow us to provide enhanced comprehensive cardiac and vascular procedures and new services to our communities,” said Morrison.  “We will be able to perform both open surgical and catheter based procedures in the same room and perform emergency procedures with less disruption to our regular schedule, which will be a great satisfier to our patients and our physicians and staff.”

The hybrid lab will be used for both catheterizations of the heart and arteries in the arms and legs.  This will provide better coordinated care with the involvement of interventional radiology and vascular surgery, as well as cardiology.

Cardiovascular disease affects more than 50 million people in the United States, more than any other disease.  Improvements in vascular screening and earlier treatment will result in lower rates of limb amputation, reduction in stroke severity and deaths, and enhanced diagnosing in patients who don’t know they have the disease and could seek treatment.